GDNF Gene Therapy Clinical Trial

GDNF Gene Therapy Clinical Trial
At the recent annual American Association of Neurological Surgeons meeting, researchers presented the results of a Phase I clinical trial designed to test the safety and tolerability of a gene therapy approach for GDNF in Parkinson's. Gene therapy involves the introduction of normal genes into cells in place of missing or defective ones in order to correct medical conditions with ... read more
Source: Published on 2019-04-30